Shanghai supports the development of biopharmaceutical industry, issues local pharmaceutical enterprises to meet opportunities

Source: great wisdom astak news agency, August 28, 2014, official website of Shanghai municipal government, in order to promote the development of biomedical industry, promote the scale, agglomeration and international development of biomedical industry, Shanghai development and Reform Commission and Shanghai Science and Technology Commission jointly formulated several policies on promoting the development of biomedical industry in Shanghai (2014) Version), clearly support the investment of industrial merger and acquisition, cultivate leading enterprises in the industry, adopt supportive price policies to support drug innovation, allocate special funds to support original projects of medical devices, etc Local pharmaceutical enterprises in Shanghai are facing development opportunities According to the policy, Shanghai will focus on introducing biomedical enterprises with strong innovation ability and good development prospects, and give policy support to the land use of industrial base; promote the leading enterprises of biomedical industry in Shanghai to merge and acquire enterprises in the same industry or upstream and downstream enterprises of industrial chain through specialized and market-oriented M & A investment; and adopt supportive price for innovative biomedical products Standard policy; select some local pharmaceutical enterprises to produce cheap common drugs and clinical drugs in short supply; give special fund support to the original projects of medical devices for the development of strategic emerging industries, simplify the audit of medical insurance payment for some medical device products, and speed up the listing; for the drugs with a certain output value, they are not subject to the time limit of the adjustment of medical insurance catalog, and are included in the medical insurance of this city preferentially Catalog, promote to become a large variety of biomedical According to the detailed rules for supporting the development of biopharmaceutical industry in Shanghai, the industry insiders believe that this is beneficial to local pharmaceutical enterprises in Shanghai and conducive to promoting the development of local pharmaceutical enterprises in Shanghai "In addition to supporting leading enterprises, we also support key varieties, including innovative drugs and medical devices, which was not expected before." It is understood that the local listed pharmaceutical enterprises in Shanghai include Shanghai Kaibao, dongfulong, kailitai, modern pharmaceutical, Fosun Pharmaceutical, Kehua biology, Shanghai Laishi, etc.